Galan Lithium gains drilling approval within Argentina's Lithium Triangle

|

Published 14-DEC-2018 11:08 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

South America-focused explorer, Galan Lithium (ASX:GLN), has now received permits from the Secretaria de Estado de Mineria – Gobierna de Catamarca (the body that approve drilling permits in Catamarca, Argentina) to undertake drilling at its Candelas Lithium Brine Project.

By way of background, GLN is exploring for lithium brines within South America’s Lithium Triangle on the Hombre Muerto salar in Argentina. Hombre Muerto is proven to host the highest grade and lowest impurity levels within Argentina and is home to Livent Corporation’s El Fenix operation and Galaxy Resources and POSCO’s Sal de Vida projects.

GLN's primary target is the adjoining Candelas channel target, a ~15km long by 3‐5km wide valley filled channel which has the potential to host a substantial volume of brine.

Field activities have already begun in preparation for drilling at Candelas.

Galan's Hombre Muerta projects

GLN will now undertake the process of awarding a number of contracts to local bodies to perform drilling, camp establishment, OH&S and technical assistance. The company has indicated it remains committed to sourcing and contracting locals of the Catamarca Province for its operations.

Initial drill holes will test the previously generated geophysical model and provide a detailed data analysis to over 400 metres deep on the stratigraphy within the Candelas channel.

The maiden drill program will comprise of five holes, which will be drilled over ~12-15km along the extent of the Candelas channel.

GLN managing director Juan Pablo Vargas de la Vega, commented on today's update: “This is a significant step forward for Galan in Argentina. Obtaining the drilling permits for our maiden campaign is a reflection of the company’s teamwork and experience in Argentina and Australia.

“The company is fully committed to swiftly unlocking the significant lithium potential at Candelas and we are now focused on finalising all the required activities needed to prepare for drilling which will start early in the New Year.”



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X